Free Sunflower Revolution Symposium to Feature Former NBA, Xavier Star Brian Grant
CINCINNATIThe 2011 Sunflower Revolution symposium, building on the motto "Move to Live & Live to Move, will feature former NBA and Xavier University basketball star Brian Grant, who was diagnosed with early-onset Parkinsons disease three years ago at age 36. He will discuss his experience with the disease and how exercise plays a crucial role in his management of Parkinsons.
The Sunflower symposium, a free educational event for patients, family members and caregivers, is hosted by the University of Cincinnati Neuroscience Institute, the James J. and Joan A. Gardner Family Center for Parkinsons Disease and Movement Disorders and UC Health.
The event will take place from 8:30 a.m. to 3 p.m. Saturday, Sept. 10, at the Oasis in Loveland, Ohio. Registration is available at www.sunflowerrev.org or by phone at (866) 941-UCNI (8264).
Grant, 6-foot, 9-inch power forward who played 12 seasons in the NBA after finishing his college career at Xavier, is the founder of the Brian Grant Foundation, which seeks to be "an informational and inspirational resource for a community of people empowered to live unique and fulfilling lives with Parkinsons disease. The organization recently launched a new website, www.poweringforward.org, to support newly diagnosed patients and their caregivers.
"My foundation wants to assure newly diagnosed Parkinsons patients that they are not alone, Grant says. "Were here to help them and their caregivers live their lives to the fullest.
Parkinsons disease is a chronic, degenerative neurological disorder that affects one in 100 people over the age of 60, the average age of disease onset. An estimated 5 to 10 percent of patients are diagnosed before age 40, with a subset of those afflicted before age 30. While the estimated number of people living with the disease varies, recent research indicates that at least 1 million people in the United States, and 6 million worldwide, suffer from Parkinsons disease.
The Sunflower symposium will present information about the latest research and treatments, as well as lifestyle interventions, exercise and dance. Program directors are Fredy Revilla, MD, director of the Gardner Center, and Kim Seroogy, PhD, director of the Selma Schottenstein Harris Laboratory for Research in Parkinsons. George Mandybur, MD, a neurosurgeon with the Mayfield Clinic and Gardner Center, will speak about current surgical management of Parkinsons disease.
The Gardner Center, a component of the UC Neuroscience Institute, is a regional referral center for patients in Greater Cincinnati and the surrounding four-state region.
The Sunflower Revolution was named and founded in 2004 by Kathleen Krumme, a Cincinnati cyclist and bicycle shop manager whose father suffered from Parkinsons disease. The sunflower is not only a familiar sight at the Tour de France, the worlds most famous cycling event, it is also a symbol of hope. In founding the Sunflower Revolution, Krumme envisioned a future revolution in the treatment of a neurological disease that currently has no cure.
The Sunflower Revolution bike ride, which is not being held in 2011, will return in 2012.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.